Drugs affecting sodium transport in human erythrocyte ghosts.
D000085:Acetates / Q000494:pharmacology; D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000779:Anesthetics, Local / Q000494:pharmacology; D001693:Biological Transport, Active / Q000187:drug effects*; D002462:Cell Membrane / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D004976:Ethacrynic Acid / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D007455:Iodine / Q000494:pharmacology; D007773:Lactates / Q000096:biosynthesis; D009840:Oligomycins / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism; D011773:Pyruvates / Q000096:biosynthesis; D012964:Sodium / Q000378:metabolism*
D000085:Acetates; D000779:Anesthetics, Local; D007773:Lactates; D009840:Oligomycins; D011773:Pyruvates; D010042:Ouabain; D004176:Dipyridamole; D005665:Furosemide; D007455:Iodine; D012964:Sodium; D000251:Adenosine Triphosphatases; D004976:Ethacrynic Acid; D007099:Imipramine; D011188:Potassium; D003891:Desipramine; D002746:Chlorpromazine